HD Secures $7.8 Million from Merck and Others to Revolutionize Healthcare Access in Southeast Asia

HD, a Southeast Asian healthcare marketplace, secures $7.8M led by Merck to fuel AI-powered platform expansion.
Matilda
HD Secures $7.8 Million from Merck and Others to Revolutionize Healthcare Access in Southeast Asia
The healthcare landscape in Southeast Asia is undergoing a rapid transformation, driven by technological advancements and evolving patient needs. A key player in this revolution is HD, a Thailand-based healthcare startup that has developed a comprehensive marketplace, HDmall, to streamline access to medical services across the region. In a significant endorsement of its innovative approach, HD has recently secured $7.8 million in equity funding, spearheaded by none other than U.S. pharmaceutical giant Merck Sharp & Dohme (MSD). This investment marks MSD's first foray into healthtech startups within the Asia Pacific region, signaling a growing recognition of HD's potential to reshape the healthcare industry. This latest funding round, which also saw participation from SBI Ven Capital, M Venture Partners, FEBE Ventures, and Partech Partners, brings HD's total funding to $18 million. It comes less than a year after the company raised $5.6 million, demonstrating the stro…